Assessment of Bioactivity of an Ethnomedicine: Hyptis suaveolens (L.) Poit

 

Amit Roy

Columbia Institute of Pharmacy, Tekari, Raipur (C.G.), India

 

 

ABSTRACT:

The work reported in this study is a part of research project that encompasses pharmacological and phytochemical investigation of some ethnopharmacologically important plants of Chhattisgarh- India. Here preliminary work done on Hyptis suaveolens (L.) Poit. (H. suaveolens), is reported as this plant is being used to treat a wide assortment of diseases by the local inhabitants of Chhattisgarh. The pharmacological potential of this plant was evaluated by using some benchtop bioassay methods like antimicrobial, antioxidant, brine shrimp lethality test (BSLT) and crown gall tumor assay. These studies were carried out to screen H. suaveolens for its bioactivity so that further study can be carried out.

 

The alcoholic extract of H. suaveolens was fractioned into chloroform soluble and insoluble fraction and both were subjected for these in vitro studies. Both the fractions of H. suaveolens methanolic extract were found to exhibit significant activity in all the bioassay models. The results were compared with those produced by standards used in each study model respectively. The present study supports that the bioassay methods are simple reliable and convenient method for assessment of bioactivity of medicinal plants and lends support for their use in traditional medicine.

 

KEYWORDS: Ethnomedicine, Hyptis suaveolens, bioassay

 

INTRODUCTION:

Hyptis suaveolens (L.) Poit. belongs to family Lamiaceae, or the mint family. They mostly exhibit aromatic or bitter-aromatic, stimulant and astringent properties. They are used as tonics, emmenagogues, diaphoretics and antispasmodics. The leaves of many members contain aromatic essential oils. H. suaveolens is considered to be stimulant, carminative, sudorific and lactagogue and is used in ethnomedicine as an anticatarrhal, anticutaneous, parasitic, and as an antipyretic. Ethnic communities of India use it for headache, to stop bleeding of the nose, as cure for sores due to fungal infection and in malarial fever. The Lodhas (a tribal community of India) use fresh leaf juice on cuts and wounds as antiseptic. In Arunachal Pradesh- India the natives use the plant leaf for itching, cough and cold1-7). Hyptis suaveolens is known as Ganga Tulsi in Chhattisgarh. Here the traditional healers use leaves externally for treatment of cancerous wound and the roots of this herb in treatment of indications that resembles brain tumor. Some healers use this herb in the form of decoction, alone or in combination with other herbs as carminative, acidity and heartburn along with number of other problems 8-13.

 

Many researchers at times only isolate and charac­terize a plethora of novel botanically-derived chemical substances without regard to bioactivities, nevertheless, to achieve applied meaning and significance in natural product study we need to incorporate bioassays14. The bioassays offer special advantages for identification of medicinal botanical extracts15. Here we have adopted four “bench top” bioassays which do not require higher animals to screen and direct the fractionation of botanical extracts in drug discovery efforts. These are: antimicrobial, antioxidant, brine shrimp lethality test (BSLT) and crown gall tumor assay.


These are general bioassays that are inexpensive, rapid, technologically simple, animal sparring and require little tech­nical training. They are capable of detecting a board spectrum of bioactivity present in crude extracts; BSLT is a general bioassay; the inhibition of crown gall tumors on discs of potato tubers is an antitumor bioassay, while antimicrobial activity and antioxidant activity helps to ascertain the presence of cytotoxicity and any significant biological activity16-22.

 

MATERIALS AND METHODS:

Plant material

The flowering whole plants were collected from the fields around the campus of Indira Gandhi Krishi Vishvavidyalaya (Agriculture University), Raipur (Chhattisgarh), India, during the months of December and January 2004-05, and the identification of plant was done by Prof. P. Jayaraman, Director Plant Anatomy Research Centre; Chennai- India. A specimen was vouchered, and deposited at Institute of Pharmacy, Pt. Ravishankar  Shukla Vishvdyalaya, Raipur; Chhattisgarh, India.

 

Test microorganisms: The microorganisms were procured from IMTECH, Chandigarh, India. Agarobacterium tumefaciens (MTCC 3329), Staphylococcus aureus (MTCC 96), Bacillus subtilis (MTCC 619), Candida albicans (MTCC 227), Escherichia coli (MTCC 1687) and Shigella sonnei (MTCC 2957).

 

Brine shrimps: The brine shrimp eggs were obtained from Southern Aquaculture, Chennai, India.

 

Preparation of the extract

One kilogram of powdered drug was packed in soxhlet apparatus and extracted with petroleum ether (60-80âC) to defat the drug. Defatted powdered drug was then extracted with ethanol (95%). The alcoholic extract thus obtained was further fractioned with chloroform into chloroform soluble and insoluble fractions. The solvents were removed by distillation and the last traces of solvent being removed under reduced pressure. The extracts and fractions were weighed and thereafter, were stored in refrigerator for further experimental work.

 

Preparations of dilutions of crude extract for antibacterial assay

The methods of Akujobi et al., (2004)23 and Esimone et al., (1998)24 were adopted with minor modifications. The crude extracts were dissolved in 30% dimethylsulphoxide (DMSO) and further diluted to obtain 5 mg/ml, 25 mg/ml, 50 mg/ml, 100 mg/ml and 200 mg/ml concentrations. These were stored at 15âC until required.

 

Disc diffusion antimicrobial bioassay

The main aim of this assay was to determine if the plant extract under investigation possess any antibiotic activity. The antimicrobial assays were performed by minimum inhibitory concentration (MIC) determination and diffusion disc methods as described earlier24- 27 with modifications.

 

In-vitro Antioxidant activity

In our work we have performed some more popular methods that were easy to perform in our laboratory conditions.

 

DPPH assay: The method followed here was introduced by Marsden Blois, more than 50 years ago28. The free radical scavenging activity of the extracts and butylated hydroxy toluene (BHT) was measured in terms of hydrogen donating or radical-scavenging ability using the stable radical DPPH29.

 

H2O2 radical scavenging activity: The ability of the extracts to scavenge hydrogen peroxide was determined according to Sundararajan et al., 200629. A solution of H2O2 was prepared in phosphate buffer (pH 7.4). H2O2 concentration was determined spectroscopically measuring absorption with extinct coefficient for H2O2. Different concentrations of extracts in distilled water were added to a H2O2 solution (0.6 ml, 40 mM). Absorbance of H2O2 at 230 nm was determined 10 min later against a blank solution containing the phosphate buffer without H2O2. a-tocopherol was used as the standard. The % of H2O2 scavenging of both the extracts and standard compound was calculated by the equation:  

 

Where,  Acont is the absorbance of the control reaction and Atest is the absorbance in the presence of the sample of the extracts.

 

Determination of reducing power: The reducing power of extracts was determined according to the method of Rajeshwar, et al., 200530. Various concentrations of the extracts in 1.0 ml of deionized water were mixed with phosphate buffer (2.5 ml, 0.2 M, pH 6.6) and 1% potassium ferricyanide (2.5 ml). The mixture was incubated at 50°C for 20 min. A portion (2.5 ml) of trichloroacetic acid (10%) was added to the mixture, which was then centrifuged at 3000 rpm for 10 min. The upper layer of the solution (2.5 ml) was mixed with distilled water (2.5 ml) and FeCl3 (0.5 ml. 0.1%) and the absorbance was measured at 700 nm. Increased absorbance of the reaction mixture indicated increased reducing power. Butylated hydroxy toluene (BHT) was used as a standard31.

 

Brine shrimp lethality test: A general bioassay that is very useful to assess the bioactivity of the plant extracts. The procedure described here has been adapted from previous studies32, 33. Brine shrimps (Artemia salina) were hatched using brine shrimp eggs in a glass vessel (1L), filled with sterile artificial seawater (prepared using sea salt 38 g/L and adjusted to pH 8.5 using 1N NaOH) under constant aeration and artificial light provided for 48 h. After hatching, active nauplii free from egg shells were collected from brighter portion of the hatching chamber and used for the assay. Nauplii were drawn through a glass capillary and placed in each vial containing 4.5 ml of brine solution and their numbers counted. In each experiment, 0.5 ml. of the plant extract was added to 4.5 ml of brine solution and maintained at room temperature for 24 h under the light and surviving larvae were counted. Experiments were conducted along with control (vehicle treated) and different concentrations of the test substances in a set of six tubes per dose. The percentage lethality was determined by comparing the mean surviving larvae of the test and control tubes and LC50 values were obtained. 

 

Crown gall tumor assay: Goal of scientists over the past years had been the development and application of crown gall tumor assay as a bench-top bioassay that is simple enough for phytochemists to use34. Modification of this assay was done by McLaughlin to perform a procedure that is rapid, inexpensive, safe, animal sparing, and a statistically reliable prescreen for in vivo murine leukemia antitumor activity34,35. For crown gall tumor assay, the procedure described by Oran47 and Hussain et al. 49 was followed with slight modification. Using sterile technique, 2 ml of bacterial growth, 0.5 ml of the sample at different concentrations (replaced by distilled water in the case of the standard), and 5 ml of distilled water were used to prepare the inoculums. Agrobacterium tumefaciens were grown on a broth medium that contained 0.5 g sucrose, 0.8 g nutrient broth, and 0.1 g yeast extract and completed to 100 ml distilled water. After sterilization in an autoclave for 12 min at 121°C and cooling, a loop containing Agrobacterium tumefaciens was added and the mixture was placed in dark for 48 h below 30°C. One and a half grams of agar were dissolved in 100 ml distilled water. After autoclaving for 15 min, 20 ml of the media were poured in each petri dish under sterile conditions and cooled. Potatoes were washed with tap water and soaked in bleach. After taking out of bleach they were cut into cylinders using a potato borer and put in a tray. The cylinders then were cut into discs, and 5 discs were placed in each Petri dish. For each sample 2–3 Petri dishes were used, in addition to those used for control. One drop of the inoculums was then added on each disc, the dishes then were wrapped with parafilm strips and kept in the dark at 27°C for 21 days. After 21 days, the discs were stained with Lugol’s solution (10% KI and 5% I2) for 30 minutes and then observed under dissecting microscope. Numbers of tumors per disc were counted and percent inhibition for each concentration was determined by the formula given below.

 

Statistical analysis

All the data were subjected to statistical analysis using SPSS 14.0 for Windows. The statistical analysis was performed by using one-way analysis-of-variance (ANOVA) followed by Dunnet’s test for individual comparison of groups with control. p-values <0.05 were considered as significant. The values are represented as the mean ± SEM for six sets of observation.

 

RESULTS AND DISCUSSION:

Disc diffusion antimicrobial bioassay

The disc diffusion method was used to determine the inhibition zones of Hyptis suaveolens extract. Results of the disc diffusion antimicrobial bioassay of the different concentrations of the extract on the test isolates and the minimum inhibitory concentrations of the extract on the test isolates are shown in table 1. The results are indicative of the fact that an increase in concentration of the extracts as well as the standard drugs results in augmented zone of inhibitions. The extract had pronounced effect on E. coli with a ZOI of 48 mm at a concentration of 200 mg/ disc and it was least effective on Shigella sonnei. The extract had moderate effect on rest of the microorganisms tested. The minimum inhibitory concentrations were 2.48, 5.61 8.52, 8.34 and 6.13 mg/ml for E.coli, B.subtilis, S.aureus, Shigella sonnei and C.albicans respectively.

 

In-vitro Antioxidant activity

DPPH scavenging activity, H2O2 radical scavenging activity and reducing power of the extract at different concentrations was evaluated to determine its antioxidant potential. The results of antioxidant activities are shown in table 2, 3 and 4, which illustrates that the tested extract has a very moderate, but definitive antioxidant capability in each of the models tested. It has an IC50 value of 30.06 µg/ ml in DPPH scavenging model compared to 18.92 µg/ml of the standard, while in H2O2 scavenging model the IC50 was 178.47mg/ml, compared to 129.84mg/ml of α-tocopherol that was used as standard. The extract had a comparable reducing power to the standard drug BHT (butylated hydroxy toluene) 

 

Brine shrimp lethality test

The results of BSLT are shown in table 5. The chloroform soluble and insoluble fractions at concentration of 10, 25, 50, 100 and 150 µg/ml was tested and showed LD50 values of 43.08 µg/ml and 66.93 µg/ml..

 

Crown gall tumor assay

Result shows that chloroform soluble fraction and chloroform insoluble fraction exhibit inhibition of tumors in potato discs in dose dependent manner and gave LD50 values of 29.71 µg/ml and 74.23 µg/ml respectively (Table 6).

 

The results of antimicrobial and antioxidant activities have shown that H. suaveolens extract exhibited both antibacterial as well as anti fungal activities. It also successfully illustrated free radical scavenging and reducing abilities.


 

Table 1: Result of disc diffusion antimicrobial bioassay

ZOI*

Microorganisms

Treatment

E.coli

B.subtilis

S.aureus

Shigella sonnei

C.albicans

H. suaveolens extract

5 mg/disc

26

14

8.4

3.1

12

25 mg/disc

31

19

13

8.8

17

50 mg/disc

35

24

16

12

22

100 mg/disc

40

30

22

15

26

200 mg/disc

48

36

28

19

33

MIC (mg/ml)

2.48

5.61

8.52

8.34

6.13

Ciprofloxacin

5 µg/disc

21

24

17

14

6.4

25 µg/disc

33

34

27

23

10

50 µg/disc

36

39

32

28

13

100 µg/disc

42

44

37

32

15

200 µg/disc

47

49

44

38

20

MIC (µg/ ml)

2.45

2.02

3.98

4.13

7.12

Ketokonazole

5 µg/disc

---

16

---

---

15

25 µg/disc

---

23

---

---

21

50 µg/disc

---

26

---

---

24

100 µg/disc

---

31

---

---

27

200 µg/disc

---

37

---

---

35

MIC (µg/ ml)

---

3.75

---

---

4.52

The results are the mean values of triplicate tests repeated three times after every 72 hours of inhibition at 370C and observations p<0.05 were considered significant. ZOI* zone of inhibition in mm; MIC minimum inhibitory concentration

 

Table 2: Result of DPPH scavenging activity

Treatment

10 µg/ml

20µg/ml

50 µg/ml

100 µg/ml

IC50

BHT

28.8±0.22

61.8± 0.70

79.8± 1.14

95.17± 1.45

18.92 µg/ml

H. suaveolens

21.6± 0.19***

54.2± 0.71***

73.1± 1.01**

90.5± 1.36*

30.06 µg/ml

Data are expressed as mean ± S.E.M., n = 6; *p<0.01 vs control, ** p< 0.001 vs control and ***p< 0.0001 vs control by students‘t’ test

 

Table 3: Result of H2O2 Radical scavenging

Treatment

50 mg/ml

100 mg/ml

200 mg/ml

300 mg/ml

350 mg/ml

IC50

α- tocopherol

31.17± 0.48

46.33± 0.84

67.67± 1.23

79.83± 1.58

88.67± 2.04

129.84mg/ml

Hyptis

20.52± 0.30***

36.67± 1.05***

60.17± 1.19***

72.17± 1.35**

81.5± 1.98*

178.47mg/ml

Data are expressed as mean ± S.E.M., n = 6; *p<0.01 vs control, ** p< 0.001 vs control and ***p< 0.0001 vs control by students‘t’ test

 

Table 4: Result of reducing Power

Treatment

100mg

200mg

500mg

600mg

1000mg

BHT

0.987± 0.02

1.25±0.02

1.61±0.02

1.8±0.05

2.28±0.06

H. suaveolens

0.92±0.02*

1.12±0.03**

1.54± 0.07

1.68± 0.02*

2.16±0.05

Data are expressed as mean ± S.E.M., n = 6; *p<0.01 vs control and ** p< 0.001 vs control by students‘t’ test

 

Table 5: Brine shrimp lethality of fractions of H. suaveolens ethanolic extract

Treatment

Percent deaths at 24 hour

LD50 mg/ml

10 mg/ml

25 mg/ml

50 mg/ml

100 mg/ml

150 mg/ml

Chloroform soluble fraction

20.62 ± 0.20

47.59 ±0.30

74.50 ± 0.58

86.32 ± 0.85

93.03 ± 1.06

43.08 ±3.68

Chloroform insoluble fraction

17.10 ± 0.15

39.02±0.22

60.90 ± 0.44

70.37 ± 0.64

76.75 ± 0.87

66.93 ±5.03

Control (only solvent)

0

0

0

0

0

-

Data analyzed by one way ANOVA; values are mean ± S.M.E., statistically significant at p < 0.05; n = 6.

 

Table 6: Crown gall tumor assay of fractions of H. suaveolens ethanolic extract

Treatment

Percent Inhibition

LD50 mg/ml

10 mg/ml

20 mg/ml

30 mg/ml

40 mg/ml

50 mg/ml

Chloroform soluble fraction

19.03 ± 0.29

43.62 ± 0.55

67.5 ±0.76

78.5 ± 0.76

85.83 ± 1.42

29.71 ± 3.09

Chloroform insoluble fraction

12.05 ± 0.08

27.60 ± 0.17

42.62 ± 0.31

49.25 ± 0.38

53.17 ± 0.53

74.23 ± 5.15

Control (only solvent)

0

0

0

0

0

-

Data analyzed by one way ANOVA; values are mean ± S.M.E., statistically significant at p < 0.05; n = 6.


These results also show that both the fractions are almost equally effective against bacteria (both gram positive and gram negative) as well as fungi; however the chloroform soluble fraction was more effective. The extracts studied in this work showed significant lethality against brine shrimp and  at the same time appreciable inhibition of tumors in potato discs. This highlights the fact that the tested extracts have antitumor properties as both of these assays have been successfully used as simple biological test to guide the fractionation process of plant extracts in order to detect antitumor compounds and have good correlation with the human solid tumor cell lines.

 

CONCLUSION:

In conclusion the two different extracts of H. suaveolens have exhibited conclusively the presence of some interesting biological activities. The results of all these in vitro studies prove a point that chloroform soluble fraction was more active than chloroform insoluble fraction. The more active fraction needs to be subjected to thorough investigation for proving its immense use in traditional medicine.

 

REFERENCES:

1.       Anonymous, 2005. The wealth of India, Raw materials, Vol. I: A, NISCIR, New Delhi, India, 158-159.

2.       Gangrade, S. K., Tripathi, N. K., Harinkhede, D. K., Mishra, P. K., 2003. Ethnomedicinal diversity used by tribals of Central India, Sam Com Digital Graphics, Indore-1, India, 144.

3.       Nadkarni, A. K., 2002. Indian Materia Medica, Vol. 1, Popular prakashan Pvt. Ltd., Mumbai, India, 84.

4.       Kashyap, K., Chand, R. (Eds), 2000. The useful plants of India, National Institute of Science Communication, CSIR, New Delhi, India, 282.

5.       Chopra, R. N., Nayar, S. L., Chopra, I. C., 1999. Glossary of Indian medicinal plants, National Institute of Science Communication, CSIR, New Delhi, India, 139.

6.       Kirtikar, K. R., Basu, B. P., 1999. Indian medicinal plants, Vo III, International book distributors, Dehradun, India, 1955-1957, 2032-2033.

7.       Rastogi, R. P. (Ed), 1998. Compendium of Indian medicinal plants Vol II- V, CDRI Lucknow and NISC New Delhi, India,384; 354-355; 397; 444.

8.       Pal, D. C., Jain, S. K., 1998. Tribal medicine, Naya Prokash, 206 Bidhan Sarani, Calcutta, p. 154.

9.       Chatterjee, A, Pakrashi, S. C., 1997. The treatise of Indian medicinal plants, Vol. V, National Institute of Science Communication, CSIR, New Delhi, p. 15.

10.     Mudgal, V., Khanna, K. K., Hajra, P. K., (Edts.) 1997. Flora of Madhya Pradesh Vol I, Botanical survey of India Allahabad, pp. 391, 403-404.

11.     Samvatsar, S., 1995. The flora of western tribal Madhya Pradesh, Scientific Publishers, Jodhpur, p. 238.

12.     Srivastava, R. C., 1989. Drug-Plant resources of Central India (An inventory), Today and Tomorrows Printers and Publishers, New Delhi, p. 72-73.

13.     Oudhia, P. In: www.botanical.com. Accessed on 4th July, 2004.

 

14.     Jerry, l. M., Lingling, l. R., 1998. The use of biological assays to evaluate botanicals, Drug Information J. 32, 513–524.

15.     Hostettmann, K., Marston, A., 2002. Twenty years of research into medicinal plants: Results and perspectives, Phytochem. Rev. 1, 275–285.

16.     Newman, D. J., Cragg, G. M., Snader, K. M., 2003. Natural products as sources of new drugs over the period 1981-2002, J Nat Prod 66, 1022 -1037.

17.     Newman, D. J., Cragg, G. M., Snader, K. M., 2000. The influence of natural products upon drug discovery, Nat Prod Rep 17, 215-234.

18.     Borris', R. P., 1996.  Natural products research: perspectives from a major pharmaceutical company, J. Ethnopharmacol. 51, 29-38.

19.     Cragg, G. M., Newman, D. J., 2005.  Biodiversity: A continuing source of novel drug leads, Pure Appl. Chem. 77, 7-24.

20.     Cragg, G. M., Newman, D. J., 2001. Natural product drug discovery in the next millennium, Pharm. Biol. 39, 8-17.

21.     Fialho Beatriz de Castro. Biodiversity and Technological Development: Opportunities for Developing Countries and the Case of Brazil, Journal of Economic Literature O31, L65, In: http://bcsia.ksg.harvard.edu/BCSIA_content/documents/fialhob.pdf. Accessed on 17th Aug. 2004.

22.     Mclaughlin, J. L., Rogers, L. L., The use of biological assays to evaluate botanicals, Drug Infor. J. 32, 513-524.

23.     Akujobi, C., Anyanwu, B. N., Onyeze, C. and Ibekwe, V. I. (2004). Antibacterial Activities and Preliminary Phytochemical Screening of Four Medicinal Plants. Journal of Applied Sciences. 7(3); 4328 – 4338.

24.     Esimone, C. O., Adiukwu, M. U. and Okonta, J. M. (1998). Preliminary Antimicrobial Screening of the Ethanolic Extract from the Lichen Usnea subfloridans (L). Journal of Pharmaceutical Research and Development. 3(2); 99 – 102.

25.     Brasileiro, G., Pizziolo, V.R., Raslan, D.S., Jamal, C.M., Silveira, D., 2006. Antimicrobial and cytotoxic activities screening of some Brazilian medicinal plants used in Governador Valadares district Beatriz. Brazilian Journal of Pharmaceutical Sciences 42, 195-202

26.     Osadebe, P. O. and Ukwueze, S. E. (2004). A Comparative Study of the Phytochemical and Antimicrobial Properties of the Eastern Nigerian Species of African Mistletoe (Loranthus micranthus) sourced from different host trees. Journal of Biological Research and Biotechnology. 2(1); 18 – 23.

27.     Digrak, M., Ahmet., Alma, I.M.H., Sen, S. 1999. Antimicrobial Activities of the Extracts of Various Plants (valex, mimosa bark, gallnut powders, Salvia sp. and Phlomis sp.) Tr. J. of Biology 23, 241-248

28.     Prakash, A., Antioxidant activity, In: http://www.terranostrachocolate.com/files/Comparative_and_General_Antioxidant_Information.pdf

29.     Sundararajan, R., Haja, N. A., Venkatesan, K., Mukherjee, K.,  Saha, B. P.,  Bandyopadhyay, A. and Mukherjee, P. K.,  2006. Cytisus scoparius link - A natural antioxidant. BMC Complementary and Alternative Medicine 6; In: http://www.biomedcentral.com/1472-6882/6/8

30.     Rajeshwar, Y., Kumar, G.P.S., Gupta, M., Mazumder, U.K., 2005. Studies on in vitro antioxidant activities of methanol extract of Mucuna pruriens (Fabaceae) seeds. European Bulletin of Drug Research 13 (1), 31-39

31.     Benkeblia, N., 2005. Free-radical scavenging capacity and antioxidant properties of some selected onions (Allium cepa L.) and garlic (Allium sativum L.) extracts, Brazilian Archives of Biology and Technology 48, 753-759.

32.     Krishnarajua, A. V., Raoa T. V. N., Sundararajua, D., Vanisreeb, M., Tsayb, H., Subbarajua, G. V., 2005. Assessment of bioactivity of Indian medicinal plants using brine shrimp (Artemia salina) lethality assay, International J Applied Sci. Eng. 3, 125-134.

33.     Finney, D. J., 1971. Probit Analysis (3rd Ed), University Press. Cambridge, pp. 37-77.

34.     Sawsan, A., 1999. Potato disc bioassay for some Jordanian medicinal plants, Oran Pharm. Biol. 37,296-299.

35.     Hussain, L.A., Zia M., Mirza, B., 2007. Cytotoxicity and antitumor potential of Fagonia cretica, Turk J Biol 31, 19-24.

 

Received on 09.11.2011

Modified on 08.12.2011

Accepted on 25.12.2011     

© A&V Publication all right reserved

Research J. Science and Tech.  4(1): Jan.-Feb. 2012: 1-5